Management of severe complications in Behçet’s disease with TNF inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of severe complications in Behçet’s disease with TNF inhibitors

Published:2017-05-19 Issue:7 Volume:17 Page:853-859
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Desbois A. C.¹²³⁴,Vallet H.¹²³⁴,Domont F.¹²³⁴,Comarmond C.¹²³⁴,Cacoub P.¹²³⁴,Saadoun D.¹²³⁴

Affiliation:

1. Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, Paris, France

2. INSERM, UMR_S 959, Paris, France

3. CNRS, FRE3632, Paris, France

4. Department of Internal Medicine and Clinical Immunology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1328496

Reference55 articles.

1. Mortality in Behçet's disease

2. The Long-Term Mortality and Morbidity of Behçet Syndrome

3. Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Behçet's disease

4. New insights into the pathogenesis of Behçet's disease

5. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Behçet’s syndrome and vascular involvement in a new rhematology clinic;Ulusal Romatoloji Dergisi;2023-11-27

2. Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance;Autoimmunity Reviews;2023-08

3. Baricitinib for the treatment of refractory vascular Behçet's disease;Clinical Immunology;2023-05

4. Candidate Drugs Screening for Behcet’s Disease Based on Bioinformatics Analysis and Mouse Experiments;Frontiers in Immunology;2022-06-21

5. Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan;Arthritis Research & Therapy;2021-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3